Healmusz Wartremober

Description

This product is identified by the code 51945-4 and is associated with the principal display panel as of January 22, 2024. The labeling includes a visual representation, which is available in JPEG format. The image is referenced as "Label.jpg" and serves to provide additional information regarding the product's packaging.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, “cauliflower-like” appearance on the surface, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. If desired, the wart may be soaked in warm water for approximately 5 minutes to facilitate the application process. After soaking, the area must be dried completely.

To apply the medication, the healthcare professional should gently squeeze the tube to dispense one drop at a time, ensuring that each wart is sufficiently covered. It is important to allow the application to dry completely after each use.

This procedure may be repeated once or twice daily as needed, continuing until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

Application on irritated skin or any area that is infected or reddened is prohibited due to the potential for exacerbating the condition. The product should not be applied to moles, birthmarks, warts with hair growth, genital warts, or warts located on the face or mucous membranes, as these areas may be sensitive or require specialized treatment.

Additionally, individuals with diabetes or poor blood circulation should not use this product, as it may pose increased risks of adverse effects in these populations.

Healthcare professionals should also advise patients to avoid contact with the eyes; in the event of exposure, the eyes should be flushed with water for 15 minutes. Inhalation of vapors should be avoided to prevent respiratory irritation.

Warnings and Precautions

For external use only; the product is flammable and should be kept away from fire and flame.

It is imperative to avoid application on irritated skin or any area that is infected or reddened. The product should not be used on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Additionally, individuals with diabetes or poor blood circulation should refrain from using this product.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center at 1-800-222-1222 without delay.

Users are advised to discontinue use and consult a healthcare professional if discomfort persists.

Side Effects

Patients should be aware that the product is for external use only and is flammable; it should be kept away from fire and flame. In the event that discomfort persists, patients are advised to stop using the product and consult a doctor. This recommendation is crucial to ensure safety and address any potential adverse reactions that may arise during use.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Healmusz Wartremober (salicylic acid 5%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The safety of salicylic acid during pregnancy has not been established, and its use is contraindicated due to potential risks to the fetus. There may be associated risks with the use of salicylic acid during pregnancy, and it should only be utilized if clearly needed, with a careful assessment of whether the benefits outweigh the risks.

Dosage modifications may be necessary for pregnant individuals, and it is advised that they consult with a healthcare provider prior to use. Special precautions should be taken, as pregnant women should avoid using this product unless directed by a healthcare professional.

Lactation

Nursing mothers should consult a healthcare professional before using this product. There is a potential for excretion in breast milk; therefore, caution is advised when administering to lactating mothers. The effects on breastfed infants are not well studied, and thus, the risks versus benefits should be carefully considered.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data regarding its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, and respiratory distress.

In the event of an overdose, immediate medical intervention is recommended. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management protocols and antidotes, if applicable. Continuous assessment and supportive measures should be prioritized until the patient stabilizes or further treatment is determined.

In summary, while specific overdosage information is not available, healthcare professionals should remain vigilant and prepared to implement standard overdose management strategies in any suspected cases.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Skin discoloration has been reported in postmarketing experience, occurring during or after the use of the product. These events have been documented through voluntary reports and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 if the product is swallowed. It is important to instruct patients not to apply the product on irritated skin or any area that is infected or reddened. Additionally, patients should be informed to avoid using the product on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes.

Patients with diabetes or poor blood circulation should be cautioned against using this product. Healthcare providers should emphasize the importance of discontinuing use and consulting a doctor if discomfort persists after application.

When using the product, patients should be advised to avoid contact with the eyes. In the event of accidental exposure to the eyes, they should flush the area with water for 15 minutes. It is also essential to inform patients to avoid inhaling vapors from the product.

Finally, healthcare providers should recommend that patients cap the product tightly and store it at room temperature, away from heat sources, to ensure its efficacy and safety.

Storage and Handling

The product is supplied in a tube format. It should be stored at room temperature, ensuring that it is kept away from excessive heat, specifically temperatures above 37°C (99°F).

To maintain product integrity, it is recommended to wipe the tip of the tube with a paper towel between uses. This practice helps to prevent contamination and ensures optimal performance of the product.

Additional Clinical Information

The product is administered topically, with the recommended frequency being once or twice daily as needed until the wart is removed, for a maximum duration of 12 weeks. Clinicians should counsel patients to avoid contact with the eyes; in the event of exposure, the eye should be flushed with water for 15 minutes. Patients are also advised to avoid inhaling vapors and to discontinue use and consult a physician if discomfort persists. In cases of ingestion, immediate medical assistance should be sought or the Poison Control Center contacted at 1-800-222-1222.

Drug Information (PDF)

This file contains official product information for Healmusz Wartremober, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)